Enhanced Accumulation and Penetration of Magnetic Nanoclusters in Tumors Using an 8-Magnet Halbach Array Leads to Improved Cancer Treatment

Overview

Journal ACS Nano

Publisher American Chemical Society

Specialty Biotechnology

Date 2025 Jan 3

PMID 39749910

Authors

Bian Jang

Ahmad Amirshaghaghi

Jeongmoon Choi

Joann Miller

David A Issadore

Theresa M Busch

Zhiliang Cheng

Andrew Tsourkas

Affiliations

Soon will be listed here.

Abstract

Nanoparticles have gained attention as drug delivery vehicles for cancer treatment, but often struggle with poor tumor accumulation and penetration. Single external magnets can enhance magnetic nanoparticle delivery but are limited to superficial tumors due to the rapid decline in the magnetic field strength with distance. We previously showed that a 2-magnet device could extend targeting to greater tissue depths. Here, we improve on this approach by constructing an 8-magnet device arranged in an annular Halbach array, which facilitates radial outward movement of magnetic nanoparticles from the bore's center. Using chlorin e6-coated magnetic nanoclusters (Ce6 clusters) with densely packed cobalt-doped superparamagnetic iron oxide nanoparticles, we demonstrated nearly a 7-fold improvement in nanoparticle movement through a porous matrix compared to the 2-magnet approach. This resulted in enhanced magnetic resonance contrast, accumulation, and penetration of Ce6 clusters into 4T1 triple-negative breast tumors in mice, leading to improved photodynamic therapy and highlighting the potential therapeutic application of the 8-magnet device.

References

Stylianopoulos T, Munn L, Jain R . Reengineering the Physical Microenvironment of Tumors to Improve Drug Delivery and Efficacy: From Mathematical Modeling to Bench to Bedside. Trends Cancer. 2018; 4(4):292-319. PMC: 5930008. DOI: 10.1016/j.trecan.2018.02.005. View

Danhier F, Feron O, Preat V . To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J Control Release. 2010; 148(2):135-46. DOI: 10.1016/j.jconrel.2010.08.027. View

Liu J, Lan Z, Ferrari C, Stein J, Higbee-Dempsey E, Yan L . Use of Oppositely Polarized External Magnets To Improve the Accumulation and Penetration of Magnetic Nanocarriers into Solid Tumors. ACS Nano. 2019; 14(1):142-152. PMC: 7002255. DOI: 10.1021/acsnano.9b05660. View

Hobson N, Weng X, Siow B, Veiga C, Ashford M, Thanh N . Clustering superparamagnetic iron oxide nanoparticles produces organ-targeted high-contrast magnetic resonance images. Nanomedicine (Lond). 2019; 14(9):1135-1152. DOI: 10.2217/nnm-2018-0370. View

Edwards M, Schuschke D, Abney D, MILLER F . Interleukin-2 acutely induces protein leakage from the microcirculation. J Surg Res. 1991; 50(6):609-15. DOI: 10.1016/0022-4804(91)90050-v. View

Su Y, Hu S . Functional Nanoparticles for Tumor Penetration of Therapeutics. Pharmaceutics. 2018; 10(4). PMC: 6321075. DOI: 10.3390/pharmaceutics10040193. View

Amirshaghaghi A, Yan L, Miller J, Daniel Y, Stein J, Busch T . Chlorin e6-Coated Superparamagnetic Iron Oxide Nanoparticle (SPION) Nanoclusters as a Theranostic Agent for Dual-Mode Imaging and Photodynamic Therapy. Sci Rep. 2019; 9(1):2613. PMC: 6385362. DOI: 10.1038/s41598-019-39036-1. View

Thorek D, Chen A, Czupryna J, Tsourkas A . Superparamagnetic iron oxide nanoparticle probes for molecular imaging. Ann Biomed Eng. 2006; 34(1):23-38. DOI: 10.1007/s10439-005-9002-7. View

Prijic S, Sersa G . Magnetic nanoparticles as targeted delivery systems in oncology. Radiol Oncol. 2012; 45(1):1-16. PMC: 3423716. DOI: 10.2478/v10019-011-0001-z. View

10.

Triesscheijn M, Baas P, Schellens J, Stewart F . Photodynamic therapy in oncology. Oncologist. 2006; 11(9):1034-44. DOI: 10.1634/theoncologist.11-9-1034. View

11.

Choi I, Strauss R, Richter M, Yun C, Lieber A . Strategies to increase drug penetration in solid tumors. Front Oncol. 2013; 3:193. PMC: 3724174. DOI: 10.3389/fonc.2013.00193. View

12.

Poltavets V, Kochetkova M, Pitson S, Samuel M . The Role of the Extracellular Matrix and Its Molecular and Cellular Regulators in Cancer Cell Plasticity. Front Oncol. 2018; 8:431. PMC: 6189298. DOI: 10.3389/fonc.2018.00431. View

13.

Feng Q, Liu Y, Huang J, Chen K, Huang J, Xiao K . Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings. Sci Rep. 2018; 8(1):2082. PMC: 5794763. DOI: 10.1038/s41598-018-19628-z. View

14.

Ernsting M, Murakami M, Roy A, Li S . Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles. J Control Release. 2013; 172(3):782-94. PMC: 3891171. DOI: 10.1016/j.jconrel.2013.09.013. View

15.

Thawani J, Amirshaghaghi A, Yan L, Stein J, Liu J, Tsourkas A . Photoacoustic-Guided Surgery with Indocyanine Green-Coated Superparamagnetic Iron Oxide Nanoparticle Clusters. Small. 2017; 13(37). PMC: 5884067. DOI: 10.1002/smll.201701300. View

16.

Senapati S, Mahanta A, Kumar S, Maiti P . Controlled drug delivery vehicles for cancer treatment and their performance. Signal Transduct Target Ther. 2018; 3:7. PMC: 5854578. DOI: 10.1038/s41392-017-0004-3. View

17.

Rizvi S, Saleh A . Applications of nanoparticle systems in drug delivery technology. Saudi Pharm J. 2018; 26(1):64-70. PMC: 5783816. DOI: 10.1016/j.jsps.2017.10.012. View

18.

Blumler P . Magnetic Guiding with Permanent Magnets: Concept, Realization and Applications to Nanoparticles and Cells. Cells. 2021; 10(10). PMC: 8535073. DOI: 10.3390/cells10102708. View

19.

Sun S, Zeng H, Robinson D, Raoux S, Rice P, Wang S . Monodisperse MFe2O4 (M = Fe, Co, Mn) nanoparticles. J Am Chem Soc. 2004; 126(1):273-9. DOI: 10.1021/ja0380852. View

20.

Shevkoplyas S, Siegel A, Westervelt R, Prentiss M, Whitesides G . The force acting on a superparamagnetic bead due to an applied magnetic field. Lab Chip. 2007; 7(10):1294-302. DOI: 10.1039/b705045c. View